A. Uccellatore

发表

The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes.

R. Testa, A. Bonfigli, A. Ceriello, 2016, Diabetes research and clinical practice.

Circulating MicroRNA-15a Associates With Retinal Damage in Patients With Early Stage Type 2 Diabetes

V. Bollati, G. Spinetti, P. de Candia, 2020, Frontiers in Endocrinology.

Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists

I. Dicembrini, E. Mannucci, A. Ceriello, 2015, Diabetes Therapy.

Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D

C. Specchia, G. Spinetti, A. Ceriello, 2019, Cardiovascular Diabetology.

Effects of Carbohydrate Counting on Glucose Control and Quality of Life Over 24 Weeks in Adult Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion

E. Bosi, A. Bolla, M. Scavini, 2011, Diabetes Care.

GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes

R. Testa, A. Ceriello, S. Genovese, 2015, Endocrine.

A unique plasma microRNA profile defines type 2 diabetes progression

C. Specchia, G. Matarese, G. Spinetti, 2017, PloS one.

A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling

L. Milanesi, R. Bellazzi, A. Puca, 2017, Scientific Reports.

Lower miR-21/ROS/HNE levels associate with lower glycemia after habit-intervention: DIAPASON study 1-year later

L. Luzi, I. Terruzzi, E. Tagliabue, 2022, Cardiovascular Diabetology.

A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling

L. Milanesi, R. Bellazzi, A. Puca, 2017, Scientific Reports.